M. Newby

发表

SARS-CoV-2 Spike- and Nucleoprotein-Specific Antibodies Induced After Vaccination or Infection Promote Classical Complement Activation

I. Henderson, M. Drayson, A. Cunningham, 2022, Frontiers in Immunology.

Variations within the Glycan Shield of SARS-CoV-2 Impact Viral Spike Dynamics

E. Fadda, Carl A. Fogarty, Joel D. Allen, 2022, bioRxiv.

Stimulation of vascular organoids with SARS-CoV-2 antigens increases endothelial permeability and regulates vasculopathy

A. Cunningham, M. Crispin, J. Allen, 2021, medRxiv.

Preferential uptake of SARS-CoV-2 by pericytes potentiates vascular damage and permeability in an organoid model of the microvasculature

A. Cunningham, Z. Stamataki, G. Taylor, 2022, Cardiovascular research.

Structural conservation of Lassa virus glycoproteins and recognition by neutralizing antibodies

B. Briney, R. Sanders, G. Boons, 2022, bioRxiv.

Severity of SARS-CoV-2 infection is associated with high numbers of alveolar mast cells and their degranulation

C. Bachert, A. Cunningham, Z. Stamataki, 2022, Frontiers in Immunology.

Single-component multilayered self-assembling protein nanoparticles presenting glycan-trimmed uncleaved prefusion optimized envelope trimers as HIV-1 vaccine candidates

Jiang Zhu, J. Copps, M. Crispin, 2022, bioRxiv.

Subtle Influence of ACE2 Glycan Processing on SARS-CoV-2 Recognition

M. Crispin, Joel D. Allen, Yasunori Watanabe, 2020, Journal of Molecular Biology.

Structure of the hepatitis C virus E1E2 glycoprotein complex

A. Ward, R. Sanders, M. Crispin, 2021, bioRxiv.

Validation of a combined ELISA to detect IgG, IgA and IgM antibody responses to SARS-CoV-2 in mild or moderate non-hospitalised patients

M. Drayson, A. Cunningham, S. Faustini, 2020, Journal of Immunological Methods.

Detection of antibodies to the SARS-CoV-2 spike glycoprotein in both serum and saliva enhances detection of infection

Mark J. Ponsford, M. Drayson, A. Cunningham, 2020, medRxiv.

Mutations in SARS-CoV-2 spike protein impair epitope-specific CD4+ T cell recognition.

G. Taylor, T. Haigh, H. Parry, 2022, Nature immunology.

Glycosylation and Serological Reactivity of an Expression-enhanced SARS-CoV-2 Viral Spike Mimetic

A. Cunningham, J. McLellan, P. Bond, 2021, Journal of Molecular Biology.

Development of a high‐sensitivity ELISA detecting IgG, IgA and IgM antibodies to the SARS‐CoV‐2 spike glycoprotein in serum and saliva

M. Drayson, A. Cunningham, M. O’Shea, 2021, Immunology.

Suppression of O-Linked Glycosylation of the SARS-CoV-2 Spike by Quaternary Structural Restraints

M. Crispin, Joel D. Allen, C. Eldrid, 2021, Analytical chemistry.

Sensitive Detection of SARS-CoV-2–Specific Antibodies in Dried Blood Spot Samples

M. Drayson, A. Cunningham, M. O’Shea, 2020, medRxiv.

In vitro, classical complement activation differs by disease severity and between SARS-CoV-2 antigens

I. Henderson, M. Drayson, A. Cunningham, 2021, medRxiv.

Influence of glycosylation on the immunogenicity and antigenicity of viral immunogens.

M. Crispin, M. Newby, J. Allen, 2023, Biotechnology advances.

Single-component multilayered self-assembling protein nanoparticles presenting glycan-trimmed uncleaved prefusion optimized envelope trimers as HIV-1 vaccine candidates

Jiang Zhu, M. Crispin, Linling He, 2023, Nature Communications.

Single-component multilayered self-assembling protein nanoparticles 1 presenting glycan-trimmed uncleaved prefusion optimized envelope trimers 2 as HIV-1 vaccine candidates 3 4

R. Lanford, Linling He, A. Antanasijevic, 2022 .